Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29591413 | 1.00 | NQO1 (0.31) | NQO1ALDH1A1 | |
| SCHEMBL23219033 | 0.86 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL29591308 | 0.86 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL23218103 | 0.79 | SIRT2 (0.42) | NQO1 | |
| SCHEMBL29591281 | 0.79 | HTR2A (0.35) | ALDH1A1 | |
| SCHEMBL23219021 | 0.79 | HTR2A (0.35) | ALDH1A1 | |
| SCHEMBL29591427 | 0.74 | — | — | |
| SCHEMBL23219022 | 0.74 | — | — | |
| SCHEMBL23218735 | 0.74 | POLB (0.40) | ALDH1A1 | |
| SCHEMBL29591463 | 0.74 | POLB (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4041238-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | Biocryst Pharmaceuticals, Inc. (US) | 2022-08-17 | — | — | EP | disclosed |
| CN-114502168-A | Oral complement factor D inhibitors | 拜奥克里斯特制药公司 | 2022-05-13 | — | — | CN | disclosed |
| WO-2021072198-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-04-15 | — | — | WO | disclosed |